Communicating product benefits and risks – now and in the future
As society and technology change, so must Pharmacovigilance.
Please complete this 3 minute survey on communication of benefit-risk information – we will present blinded, aggregated results in a future publication.
Thank you for your participation!
Huron’s life science practice is part of Huron’s continuum of healthcare offerings supporting the development and commercialization of pharmaceutical products and services.